Lilly & Co Eli Zymeworks Inc. (ZYME) insider trading activity

ZYME Quotes by TradingView

Lilly & CO Eli is > 10% Shareholder of Zymeworks Inc.. Currently has a direct ownership of 2.9 Million shares of ZYME, which is worth approximately $40.2 Million. The most recent transaction as insider was on Jan 31, 2019, when has been sold 250,000 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $4,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.9M
0% 3M change
0% 12M change
Total Value Held $40.2 Million

LILLY & Co ELI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2019
SELL
Open market or private sale
$4,000,000 $16.0 p/Share
250,000 Reduced 7.94%
2,898,647 Common Stock
Nov 06 2018
SELL
Open market or private sale
$9,800,000 $14.0 p/Share
700,000 Reduced 18.19%
3,148,647 Common Stock
Sep 24 2018
SELL
Open market or private sale
$33,162 $16.36 p/Share
2,027 Reduced 0.05%
3,848,647 Common Stock
Sep 18 2018
SELL
Open market or private sale
$100,027 $14.56 p/Share
6,870 Reduced 0.18%
3,850,674 Common Stock
Sep 17 2018
SELL
Open market or private sale
$100,092 $14.58 p/Share
6,865 Reduced 0.18%
3,857,544 Common Stock
Sep 14 2018
SELL
Open market or private sale
$131,351 $14.58 p/Share
9,009 Reduced 0.23%
3,864,409 Common Stock
Sep 13 2018
SELL
Open market or private sale
$299,288 $14.32 p/Share
20,900 Reduced 0.54%
3,873,418 Common Stock
Sep 12 2018
SELL
Open market or private sale
$149,175 $14.83 p/Share
10,059 Reduced 0.26%
3,894,318 Common Stock
Sep 11 2018
SELL
Open market or private sale
$167,689 $14.87 p/Share
11,277 Reduced 0.29%
3,904,377 Common Stock
Sep 10 2018
SELL
Open market or private sale
$64,980 $14.44 p/Share
4,500 Reduced 0.11%
3,915,654 Common Stock
Aug 31 2018
SELL
Open market or private sale
$9,982 $14.26 p/Share
700 Reduced 0.02%
3,920,154 Common Stock
Aug 30 2018
SELL
Open market or private sale
$49,364 $14.35 p/Share
3,440 Reduced 0.09%
3,920,854 Common Stock
Aug 29 2018
SELL
Open market or private sale
$32,969 $14.26 p/Share
2,312 Reduced 0.06%
3,924,294 Common Stock
Aug 14 2018
SELL
Open market or private sale
$42,840 $14.28 p/Share
3,000 Reduced 0.08%
3,926,606 Common Stock
Aug 13 2018
SELL
Open market or private sale
$64,929 $14.33 p/Share
4,531 Reduced 0.12%
3,929,606 Common Stock
Aug 10 2018
SELL
Open market or private sale
$27,103 $14.28 p/Share
1,898 Reduced 0.05%
3,934,137 Common Stock
Aug 03 2018
SELL
Open market or private sale
$22,358 $13.55 p/Share
1,650 Reduced 0.04%
3,936,035 Common Stock
Aug 02 2018
SELL
Open market or private sale
$258,214 $13.31 p/Share
19,400 Reduced 0.49%
3,937,685 Common Stock

Also insider at

CLCD
CoLucid Pharmaceuticals, Inc.
> 10% Shareholder
LPTX
LEAP THERAPEUTICS, INC. Healthcare
> 10% Shareholder
ELAN
Elanco Animal Health Inc Healthcare
> 10% Shareholder
RNA
Avidity Biosciences, Inc. Healthcare
SGTX
Sigilon Therapeutics, Inc. Healthcare
> 10% Shareholder
L&C

Lilly & CO Eli

> 10% Shareholder
Indianapolis, IN

Track Institutional and Insider Activities on ZYME

Follow Zymeworks Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZYME shares.

Notify only if

Insider Trading

Get notified when an Zymeworks Inc. insider buys or sells ZYME shares.

Notify only if

News

Receive news related to Zymeworks Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ZYME